La insoportable levedad del ser 'pacto sucesorio europeo'

Autor: Francesco Maiello

Publikováno v: Democrazia e Diritti Sociali, Vol 2022, Iss 1, Pp 87-94 (2022)

The main aim of this article is to address the issue of agreements as to succession in the light of the Regulation (EU) No 650/2012 of the European Parliament and of the Council of 4 July 2012 on jurisdiction, applicable law, recognition and enforcem

Externí odkaz: https://doaj.org/article/7988ae9091434c8e81b513bdbd9a0fc4

Brooke-Spiegler syndrome presenting multiple concurrent cutaneous and parotid gland neoplasms: Cytologic findings on fine-needle sample and description of a novel mutation of the CYLD gene

Autor: B D Maria Gabriella Malzone, Gerardo Botti, Franco Fulciniti, Franco Ionna, Francesco Caponigro, B D Claudia Martinuzzi, Francesco Maiello, Francesco Longo, Concetta Schiavone, Francesco Perri, B D Anna Cipolletta Campanile, B D Sabina Nasti, Nunzia Simona Losito

Publikováno v: Diagnostic Cytopathology. 43:654-658

Multiple dermal cylindromas and membranous basal cell adenoma of parotid gland in a 67-year-old woman with Brooke-Spiegler syndrome (BSS) were examined by fine-needle cytology. Histology, immunochemistry, and CYLD germline mutation testing were also

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d41660f2da6d9d968c2526c21d0a37c2
https://doi.org/10.1002/dc.23275

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease

Autor: Vincenzo Di Marzo, Giovanni Battista, Ester Pagano, Diana Coppola, Barbara Romano, Ines Fasolino, Francesco Maiello, Angelo A. Izzo, Pierangelo Orlando, Francesca Borrelli, Raffaele Capasso

Publikováno v: Biochemical pharmacology 85 (2013): 1306–1316. doi:10.1016/j.bcp.2013.01.017
info:cnr-pdr/source/autori:Borrelli F a, Fasolino I a, Romano B a, Capassoi R a, Maiello F b, Coppola D b, Orlando P c, Battista G b, Pagano E a, Di Marzo V d, Izzo AA a./titolo:Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease./doi:10.1016%2Fj.bcp.2013.01.017/rivista:Biochemical pharmacology/anno:2013/pagina_da:1306/pagina_a:1316/intervallo_pagine:1306–1316/volume:85

Inflammatory bowel disease (IBD) is an incurable disease which affects millions of people in industrialised countries. Anecdotal and scientific evidence suggest that Cannabis use may have a positive impact in IBD patients. Here, we investigated the e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d930f5641860a4e9cbf3178a9563105
https://doi.org/10.1016/j.bcp.2013.01.017

Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid

Autor: Francesca Borrelli, Ester Pagano, Barbara Romano, Stefania Panzera, Diana Coppola, Lorena Buono, Angelo A. Izzo, Luciano De Petrocellis, Francesco Maiello, Pierangelo Orlando

Publikováno v: Carcinogenesis (N.Y., Print) (2014). doi:10.1093/carcin/bgu205
info:cnr-pdr/source/autori:Borrelli F, Pagano E, Romano B, Panzera S, Maiello F, Coppola D, De Petrocellis L, Buono L, Orlando P, Izzo AA./titolo:Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid./doi:10.1093%2Fcarcin%2Fbgu205/rivista:Carcinogenesis (N.Y., Print)/anno:2014/pagina_da:/pagina_a:/intervallo_pagine:/volume

Cannabigerol (CBG) is a safe non-psychotropic Cannabis-derived cannabinoid (CB), which interacts with specific targets involved in carcinogenesis. Specifically, CBG potently blocks transient receptor potential (TRP) M8 (TRPM8), activates TRPA1, TRPV1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e420c221f2b99eee1b7bd515429ef78b
https://pubmed.ncbi.nlm.nih.gov/25269802

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

Autor: Vincenzo Di Marzo, Angelo A. Izzo, Francesco Capasso, Pierangelo Orlando, Gabriella Aviello, Raffaele Capasso, Stefania Petrosino, Federico Guadagno, Barbara Romano, Francesca Borrelli, Francesco Maiello

Publikováno v: Journal of molecular medicine (Berl., Print) 87 (2009): 1111–1121. doi:10.1007/s00109-009-0512-x
info:cnr-pdr/source/autori:Borrelli F.; Aviello G.; Romano B.; Orlando P.; Capasso R.; Maiello F.; Guadagno F.; Petrosino S.; Capasso F.; Di Marzo V.; Izzo A.A./titolo:Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis/doi:10.1007%2Fs00109-009-0512-x/rivista:Journal of molecular medicine (Berl., Print)/anno:2009/pagina_da:1111/pagina_a:1121/intervallo_pagine:1111–1121/volume:87

Inflammatory bowel disease affects millions of individuals; nevertheless, pharmacological treatment is disappointingly unsatisfactory. Cannabidiol, a safe and non-psychotropic ingredient of marijuana, exerts pharmacological effects (e.g., antioxidant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8e66935a698bb11c4f6b48a9990543e
http://hdl.handle.net/11588/355035